logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Class
    3. Central Nervous System Stimulant

    Central Nervous System Stimulant class drugs

    FiltersReset Filters
    41 results

    • amphetamine sulfate

      (Amphetamine Sulfate)
      Wilshire Pharmaceuticals
      Usage: Amphetamine Sulfate Tablets are indicated for the treatment of narcolepsy, Attention Deficit Disorder with Hyperactivity, and as a short-term adjunct for exogenous obesity within a calorie-restricted weight loss regimen for patients unresponsive to other therapies.

    • amphetamine sulfate

      (Amphetamine Sulfate)
      Epic Pharma LLC
      Usage: Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity as part of a comprehensive treatment program, and short-term adjunct treatment for exogenous obesity in patients unresponsive to alternative weight loss methods.

    • amphetamine sulfate

      (Amphetamine Sulfate)
      SpecGx LLC
      Usage: Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity as part of a comprehensive treatment approach, and short-term management of exogenous obesity in patients not responding to other weight reduction therapies.

    • azstarys

      (Serdexmethylphenidate and Dexmethylphenidate)
      Corium, LLC.
      Usage: AZSTARYS is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older.

    • butalbital, acetaminophen and caffeine

      (BUTALBITAL, ACETAMINOPHEN AND CAFFEINE)
      Chartwell RX, LLC
      Usage: Butalbital, acetaminophen, and caffeine tablets are indicated for relieving tension headache symptoms. There is insufficient evidence supporting their efficacy for multiple recurrent headaches. Caution is advised due to the habit-forming and potentially abusable nature of butalbital.

    • butalbital, acetaminophen, and caffeine

      (Butalbital, Acetaminophen, and Caffeine)
      Actavis Pharma, Inc.
      Usage: Butalbital, Acetaminophen, and Caffeine Capsules are indicated for relieving tension or muscle contraction headaches. However, the safety and efficacy for treating multiple recurrent headaches are not established, and caution is advised due to the potential for habit formation and abuse.

    • butalbital, acetaminophen, and caffeine

      (Butalbital, Acetaminophen, and Caffeine)
      Actavis Pharma, Inc.
      Usage: Butalbital, acetaminophen, and caffeine tablets are indicated for relieving tension (or muscle contraction) headaches. Their efficacy for multiple recurrent headaches is not well-supported, and caution is advised due to the habit-forming potential of butalbital.

    • butalbital, acetaminophen, caffeine, and codeine phosphate

      (Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate)
      Actavis Pharma, Inc.
      Usage: Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are used to manage tension headaches when non-opioid treatments are insufficient. They should be reserved for cases where alternative options are intolerable or ineffective, and not be used long-term unless pain remains severe and alternative treatments fail.

    • butalbital, acetaminophen, caffeine, and codeine phosphate

      (Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate)
      Actavis Pharma, Inc.
      Usage: Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are indicated for managing tension headaches when non-opioid analgesics are ineffective. Due to addiction risks, they are reserved for patients who cannot tolerate or achieve adequate pain relief from alternative treatments.

    • butalbital, aspirin, and caffeine

      (butalbital, aspirin, and caffeine)
      Chartwell RX, LLC
      Usage: Butalbital, aspirin, and caffeine capsules are indicated for relieving tension or muscle contraction headache symptoms. There is insufficient evidence for their efficacy in multiple recurrent headaches. Caution is advised due to the potential for habit formation and abuse associated with butalbital.